A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with moderate/severe, chronic cancer pain.

2012 Jan 1

01/01/2012

PubMed:

Palliat Med 2012;26:50-60.

By Ahmedzai SH, Nauck F, Bar-Sela G, Bosse B, Leyendecker P, Hopp M.

Objective: An examination of whether oxycodone/naloxone prolonged-release tablets (OXN PR) can improve constipation and maintain analgesia, compared with oxycodone prolonged-release tablets (OxyPR) in patients with moderate/severe cancer pain.

Methods: Randomized, double-blind, active-controlled, double-dummy, parallel-group study in which 185 patients were randomized to receive up to 120 mg/day of OXN PR or OxyPR over 4 weeks. Efficacy assessments included Bowel Function Index (BFI), Brief Pain Inventory Short-Form (BPI-SF), laxative and rescue medication use. Quality of life (QoL) and safety assessments were conducted.

Results: After 4 weeks, mean BFI score was significantly lower with OXN PR; mean total laxative intake was 20% lower with OXN PR. Mean BPI-SF scores were similar for both treatments and the average rate of analgesic rescue medication use was low and comparable. QoL assessments were stable and comparable with greater improvements in constipation-specific QoL assessments with OXN PR. Overall, rates of adverse drug reactions were similar.

Conclusions: OXN PR provides superior bowel function in cancer pain patients, compared with OxyPR, without compromising analgesic efficacy or safety. This study confirms that OXN PR is well tolerated and efficacious in cancer pain patients and results are in line with those seen in non-malignant pain patients.

More publications on the subject

Feasibility study of a systematic approach for discontinuation of multiple medications in older adults: addressing polypharmacy

Background: Polypharmacy and inappropriate medication use is a problem in elderly patients, who are more likely to experience adverse effects from multiple treatments and less

The oncologist’s role in delivering palliative care

Abstract Given that such a substantial proportion of oncology patients have advanced and/or incurable cancer oncologists invariably face enormous challenges in maintaining or improving

The cultural context of patient’s autonomy and doctor’s duty: passive euthanasia and advance directives in Germany and Israel

01/11/2010

Abstract The moral discourse surrounding end-of-life (EoL) decisions is highly complex, and a comparison of Germany and Israel can highlight the impact of cultural

Selected issues in palliative care among East Jerusalem Arab residents

01/01/2010

Abstract Understanding of cultural context is important when working with Palestinian patients, particularly in Israeli hospitals. Cultural competence includes individual assessment of communication needs

End-of-life needs as perceived by terminally ill older adult patients, family and staff

01/09/2010

Abstract Purpose of the study: A comparison of inpatient end-of-life needs as perceived by terminally ill older adult patients, family, physicians and nurses, is lacking.

The cultural context of end-of-life ethics: a comparison of Germany and Israel

01/07/2010

No abstract available